{"url":"https://nivawealth.com/firms/bleichroeder-304295","iapdUrl":"https://adviserinfo.sec.gov/firm/summary/304295","regulatoryAum":2431232134,"crd":"304295","history":[{"filedOn":"2021-06-03","regulatoryAum":2211960355,"clients":57,"employees":8,"offices":1},{"filedOn":"2022-04-28","regulatoryAum":2851166193,"clients":59,"employees":10,"offices":1},{"filedOn":"2023-03-29","regulatoryAum":2259758925,"clients":59,"employees":8,"offices":1},{"filedOn":"2024-03-28","regulatoryAum":2229687614,"clients":60,"employees":8,"offices":1},{"filedOn":"2025-03-28","regulatoryAum":2228876680,"clients":56,"employees":7,"offices":1},{"filedOn":"2026-09-23","regulatoryAum":2431232134,"clients":57,"employees":12,"offices":1}],"secFileNumber":"801-117171","legalName":"Bleichroeder LP","displayName":"Bleichroeder","slug":"bleichroeder-304295","website":"https://bleichroederlp.com/","logo":{"src":"https://rmkhnxnbeclogprvkfyl.supabase.co/storage/v1/object/public/firm-logos/304295/392c5a3a6a6bfdfd-r1.webp","tone":"light","width":1741,"height":200,"sourceUrl":"https://bleichroederlp.com/","sourceLabel":"Bleichroeder LP, website"},"classification":{"segment":"private_funds","segmentLabel":"Private funds","type":"private_fund_manager","typeLabel":null,"feeDisclosure":"payment_only"},"founded":null,"organization":"Delaware limited partnership","fiscalYearEnd":"December","headquarters":{"street":"1345 Avenue of the Americas, 47th Floor","city":"New York","state":"NY","stateName":"New York","country":"United States","postalCode":"10105"},"tradeNames":[],"registration":{"secApproved":"12 August 2019","noticeFilings":null,"latestNoticeFiling":null},"wealthAumPerClient":12888596.787878787,"staff":{"employees":12,"advisory":10,"brokerDealerReps":0,"insuranceAgents":0,"promoters":0},"aum":{"regulatory":2431232134,"discretionary":2431232134,"discretionaryAccounts":57,"nonDiscretionary":0,"nonDiscretionaryAccounts":0,"wrapProgram":null,"nonUsClientsPct":18,"nonAumClients":0},"clientTypes":[{"label":"Individuals (other than HNW)","clients":33,"regulatoryAum":425323694},{"label":"Pooled investment vehicles","clients":5,"regulatoryAum":1003584763},{"label":"Charitable organizations","clients":6,"regulatoryAum":935768623},{"label":"Corporations and other businesses","clients":13,"regulatoryAum":66555054}],"feePrograms":[],"brochureCoverage":{"scope":"known_documents","status":"not_processed","checkedAt":null,"documents":[]},"custodians":[{"name":"Bank of America Private Bank","shortName":"Bank of America Private Bank","location":"Dallas, TX","smaAssets":1207206389}],"custodyNote":"Bleichroeder has custody of $809M in client assets for 4 clients.","otherCustodians":[],"leadership":[{"name":"Andrew Gundlach","title":"Chairman and Chief Executive Officer","crd":"2520865"},{"name":"Daniiar Tashbekov","title":"Chief Compliance Officer","crd":"8347101"}],"ownership":[{"label":"Bleichroeder Holdings LLC","detail":"General partner in the 75% or more ownership band and a control person, since July 2019."},{"label":"Andrew Gundlach","detail":"Indirect owner: trustee of Asg 2019 Irrv TR and a control person, since July 2019.","parent":"Asg 2019 Irrv TR"},{"label":"Asg 2019 Irrv TR","detail":"Indirect owner: a member of Bleichroeder Holdings LLC in the 75% or more band and a control person, since July 2019.","parent":"Bleichroeder Holdings LLC"}],"branchOffices":null,"filedOffices":{"otherThanPrincipal":0,"privateResidences":0},"listedOfficeAddresses":1,"foreignOffices":[],"officesByState":[{"state":"New York","offices":1,"addresses":[{"street":"1345 Avenue of the Americas, 47th Floor","city":"New York","headquarters":true}]}],"advFacts":{"source":{"file":"ia100226.zip","asOf":"2 October 2026"},"telephone":"212-984-3815","stateRegisteredReps":0,"otherAdviserReps":0,"compensation":["A percentage of assets under management","Fixed fees (other than subscription fees)","Performance-based fees"],"activities":["Portfolio management for individuals and/or small businesses","Portfolio management for pooled investment vehicles (other than investment companies)","Portfolio management for businesses (other than small businesses) or institutional clients"],"financialPlanningClients":null,"assetMix":[{"label":"Exchange-traded equity securities","percent":16},{"label":"Securities issued by pooled investment vehicles (other than registered investment companies)","percent":39},{"label":"Cash and cash equivalents","percent":36},{"label":"Other","percent":12,"detail":"Tangible Assets and Other Non-Investable Assets."}],"privateFunds":5},"sources":{"adv1FilingDate":"23 September 2026","adv1Url":"https://reports.adviserinfo.sec.gov/reports/ADV/304295/PDF/304295.pdf","brochureDate":null,"brochureUrl":null,"iapdCompiledDate":null,"retrievedDate":"15 October 2026","retrievedOn":"2026-10-15","updatedOn":"2026-10-21","holdingsUpdatedOn":"2026-10-21","adv1Pages":{},"brochurePages":{}},"otherBusiness":[],"faq":[{"question":"How many clients does Bleichroeder have?","answer":"Bleichroeder has 57 clients and manages $2.43 billion for them, as of September 2026. They include 33 individuals, 13 corporations and other businesses, and 6 charitable organizations.","source":"Form ADV Part 1A, Items 5.D and 5.F, filed 23 September 2026","sourceRef":{"doc":"adv1","section":"employees"}},{"question":"What services does Bleichroeder offer?","answer":"Bleichroeder provides portfolio management for individuals and small businesses, portfolio management for pooled vehicles, and portfolio management for institutions.","source":"Form ADV Part 1A, Item 5.G, from the SEC's 2 October 2026 data file","sourceRef":{"doc":"adv1","section":"employees"}},{"question":"Which custodians does Bleichroeder use?","answer":"Bleichroeder’s separately managed account assets are held at Bank of America Private Bank (Dallas, TX), with $1.21B. Only custodians holding at least a tenth of those assets are named.","source":"Form ADV Part 1A, Schedule D, Section 5.K.(3), filed 23 September 2026","sourceRef":{"doc":"adv1","section":"custodians"}},{"question":"How many financial advisors does Bleichroeder have?","answer":"Bleichroeder has 0 investment adviser representatives registered with state securities authorities, out of 12 employees, and 10 perform investment advisory functions. None are registered representatives of a broker-dealer or licensed insurance agents.","source":"Form ADV Part 1A, Items 5.A and 5.B, from the SEC's 2 October 2026 data file","sourceRef":{"doc":"adv1","section":"employees"}},{"question":"What does Bleichroeder invest in?","answer":"At the end of its last fiscal year, Bleichroeder’s separately managed accounts held 39% pooled vehicles (private funds and similar), 36% cash and equivalents, 16% exchange-traded equities and 12% other. The 12% other category is described as: Tangible Assets and Other Non-Investable Assets. It advises 5 private funds.","source":"Form ADV Part 1A, Items 5.K.(1) and 7.B, from the SEC's 2 October 2026 data file","sourceRef":{"doc":"adv1","section":"employees"}},{"question":"Who owns Bleichroeder?","answer":"Bleichroeder’s direct owner is Bleichroeder Holdings LLC (75% or more).","source":"Form ADV Part 1A, Schedules A and B, filed 23 September 2026","sourceRef":{"doc":"adv1","section":"scheduleA"}},{"question":"How does Bleichroeder get paid?","answer":"Bleichroeder is paid through a percentage of assets under management, fixed fees and performance-based fees. Its Form ADV lists no commissions among how it is paid.","source":"Form ADV Part 1A, Item 5.E, from the SEC's 2 October 2026 data file","sourceRef":{"doc":"adv1","section":"employees"}},{"question":"How do I contact Bleichroeder?","answer":"Bleichroeder’s main office is at 1345 Avenue of the Americas, 47th Floor, New York, NY 10105. Its phone number is 212-984-3815. Its website is bleichroederlp.com.","source":"Form ADV Part 1A, Item 1.F, filed 23 September 2026","sourceRef":{"doc":"adv1","section":"offices"}}],"holdings":{"url":"https://nivawealth.com/firms/bleichroeder-304295/holdings","form":"13F-HR","periodOfReport":"2026-06-30","filedOn":"2026-08-13","filingIndexUrl":"https://www.sec.gov/Archives/edgar/data/1781002/000142050626001619/0001420506-26-001619-index.html","totalValue":558937707,"positionCount":78,"top10Share":0.7752325358861502,"top10":[{"issuer":"SPDR GOLD TR","titleOfClass":"GOLD SHS","cusip":"78463V107","value":174980500,"shares":475000,"shareType":"SH","priorValue":204387750,"priorShares":475000},{"issuer":"GPGI INC","titleOfClass":"COM CL A","cusip":"20459V105","value":62958985,"shares":3972176,"shareType":"SH","priorValue":67881454,"priorShares":3969676},{"issuer":"STATE STR SPDR S&P 500 ETF T","titleOfClass":"TR UNIT","cusip":"78462F103","value":50515257,"shares":67645,"shareType":"SH","priorValue":43992249,"priorShares":67645},{"issuer":"RESOLUTE HLDGS MGMT INC","titleOfClass":"COM","cusip":"76134H101","value":45406412,"shares":314166,"shareType":"SH","priorValue":50989142,"priorShares":314166},{"issuer":"LINDE PLC","titleOfClass":"SHS","cusip":"G54950103","value":31361620,"shares":60434,"shareType":"SH","priorValue":33946670,"priorShares":68474},{"issuer":"DUOS TECHNOLOGIES GROUP INC","titleOfClass":"COM","cusip":"266042407","value":19533672,"shares":1627806,"shareType":"SH","priorValue":11166749,"priorShares":1627806},{"issuer":"PRECISION BIOSCIENCES INC","titleOfClass":"COM NEW","cusip":"74019P207","value":15862973,"shares":2018190,"shareType":"SH","priorValue":9143750,"priorShares":1662500},{"issuer":"CUE BIOPHARMA INC","titleOfClass":"COM","cusip":"22978P205","value":11698724,"shares":370682,"shareType":"SH"},{"issuer":"BLACKSTONE INC","titleOfClass":"COM","cusip":"09260D107","value":10678553,"shares":90750,"shareType":"SH","priorValue":10435343,"priorShares":90750},{"issuer":"IMMIX BIOPHARMA INC","titleOfClass":"COM","cusip":"45258H106","value":10310000,"shares":1000000,"shareType":"SH","priorValue":9110000,"priorShares":1000000}],"positionsListed":78,"positions":[{"issuer":"SPDR GOLD TR","titleOfClass":"GOLD SHS","cusip":"78463V107","value":174980500,"shares":475000,"shareType":"SH","priorValue":204387750,"priorShares":475000},{"issuer":"GPGI INC","titleOfClass":"COM CL A","cusip":"20459V105","value":62958985,"shares":3972176,"shareType":"SH","priorValue":67881454,"priorShares":3969676},{"issuer":"STATE STR SPDR S&P 500 ETF T","titleOfClass":"TR UNIT","cusip":"78462F103","value":50515257,"shares":67645,"shareType":"SH","priorValue":43992249,"priorShares":67645},{"issuer":"RESOLUTE HLDGS MGMT INC","titleOfClass":"COM","cusip":"76134H101","value":45406412,"shares":314166,"shareType":"SH","priorValue":50989142,"priorShares":314166},{"issuer":"LINDE PLC","titleOfClass":"SHS","cusip":"G54950103","value":31361620,"shares":60434,"shareType":"SH","priorValue":33946670,"priorShares":68474},{"issuer":"DUOS TECHNOLOGIES GROUP INC","titleOfClass":"COM","cusip":"266042407","value":19533672,"shares":1627806,"shareType":"SH","priorValue":11166749,"priorShares":1627806},{"issuer":"PRECISION BIOSCIENCES INC","titleOfClass":"COM NEW","cusip":"74019P207","value":15862973,"shares":2018190,"shareType":"SH","priorValue":9143750,"priorShares":1662500},{"issuer":"CUE BIOPHARMA INC","titleOfClass":"COM","cusip":"22978P205","value":11698724,"shares":370682,"shareType":"SH"},{"issuer":"BLACKSTONE INC","titleOfClass":"COM","cusip":"09260D107","value":10678553,"shares":90750,"shareType":"SH","priorValue":10435343,"priorShares":90750},{"issuer":"IMMIX BIOPHARMA INC","titleOfClass":"COM","cusip":"45258H106","value":10310000,"shares":1000000,"shareType":"SH","priorValue":9110000,"priorShares":1000000},{"issuer":"INTELLICHECK MOBILISA INC","titleOfClass":"COM NEW","cusip":"45817G201","value":8431006,"shares":2056343,"shareType":"SH","priorValue":14494345,"priorShares":2073583},{"issuer":"S&P GLOBAL INC","titleOfClass":"COM","cusip":"78409V104","value":8145200,"shares":20000,"shareType":"SH","priorValue":8506800,"priorShares":20000},{"issuer":"IDENTIV INC","titleOfClass":"COM NEW","cusip":"45170X205","value":7268927,"shares":2884495,"shareType":"SH","priorValue":10672632,"priorShares":2884495},{"issuer":"LIQTECH INTL INC","titleOfClass":"COM","cusip":"53632A300","value":5843021,"shares":6882239,"shareType":"SH","priorValue":6078076,"priorShares":3182239},{"issuer":"KAZIA THERAPEUTICS LTD","titleOfClass":"SPONSORED ADS","cusip":"48669G303","value":5632000,"shares":400000,"shareType":"SH","priorValue":2976000,"priorShares":400000},{"issuer":"ENVOY MEDICAL INC","titleOfClass":"CL A","cusip":"29415V109","value":4950000,"shares":6250000,"shareType":"SH","priorValue":4156875,"priorShares":6250000},{"issuer":"CULLINAN THERAPEUTICS INC","titleOfClass":"COM","cusip":"230031106","value":4552500,"shares":250000,"shareType":"SH","priorValue":1421000,"priorShares":100000},{"issuer":"WELLTOWER INC","titleOfClass":"COM","cusip":"95040Q104","value":4539400,"shares":20000,"shareType":"SH","priorValue":3954200,"priorShares":20000},{"issuer":"EYEPOINT INC","titleOfClass":"COM NEW","cusip":"30233G209","value":4526165,"shares":316515,"shareType":"SH","priorValue":4079878,"priorShares":316515},{"issuer":"FLUENT INC","titleOfClass":"COM NEW","cusip":"34380C201","value":4262857,"shares":1142857,"shareType":"SH","priorValue":4514284,"priorShares":1428571},{"issuer":"GENELUX CORPORATION","titleOfClass":"COM","cusip":"36870H103","value":4155805,"shares":1380666,"shareType":"SH","priorValue":3341212,"priorShares":1380666},{"issuer":"PROKIDNEY CORP","titleOfClass":"SHS CL A","cusip":"74291D104","value":4080000,"shares":2000000,"shareType":"SH","priorValue":3580000,"priorShares":2000000},{"issuer":"COGENT BIOSCIENCES INC","titleOfClass":"COM","cusip":"19240Q201","value":3870000,"shares":100000,"shareType":"SH"},{"issuer":"INVESCO QQQ TR","titleOfClass":"UNIT SER 1","cusip":"46090E103","value":3416896,"shares":4640,"shareType":"SH","priorValue":2678115,"priorShares":4640},{"issuer":"JPMORGAN CHASE & CO","titleOfClass":"COM","cusip":"46625H100","value":3338766,"shares":10200,"shareType":"SH","priorValue":4412400,"priorShares":15000},{"issuer":"MDXHEALTH SA","titleOfClass":"SHS NEW","cusip":"B5950S113","value":3029544,"shares":7378333,"shareType":"SH","priorValue":16970166,"priorShares":7378333},{"issuer":"OPUS GENETICS INC","titleOfClass":"COM","cusip":"67577R102","value":3028421,"shares":736842,"shareType":"SH","priorValue":3352631,"priorShares":736842},{"issuer":"GRUPO TELEVISA S A B","titleOfClass":"SPON ADR REP ORD","cusip":"40049J206","value":2791300,"shares":1030000,"shareType":"SH","priorValue":2997300,"priorShares":1030000},{"issuer":"BARFRESH FOOD GROUP INC","titleOfClass":"COM NEW","cusip":"067532200","value":2781516,"shares":1390758,"shareType":"SH","priorValue":3908030,"priorShares":1390758},{"issuer":"DIAMEDICA THERAPEUTICS INC","titleOfClass":"COM NEW","cusip":"25253X207","value":2691512,"shares":382317,"shareType":"SH","priorValue":2588286,"priorShares":382317},{"issuer":"RANK ONE COMPUTING CORP","titleOfClass":"COM SHS","cusip":"753040104","value":2635000,"shares":500000,"shareType":"SH","priorValue":3495000,"priorShares":500000},{"issuer":"SPIRE GLOBAL INC","titleOfClass":"COM CL A NEW","cusip":"848560306","value":2511000,"shares":135000,"shareType":"SH"},{"issuer":"IDEAL PWR INC","titleOfClass":"COM NEW","cusip":"451622203","value":2144000,"shares":400000,"shareType":"SH","priorValue":849000,"priorShares":300000},{"issuer":"NEUROONE MED TECHNOLOGIES CO","titleOfClass":"COM","cusip":"64130M308","value":2026665,"shares":666666,"shareType":"SH"},{"issuer":"CURIS INC","titleOfClass":"COM","cusip":"231269309","value":1985196,"shares":3802329,"shareType":"SH","priorValue":2081015,"priorShares":3802329},{"issuer":"REVOLUTION MEDICINES INC","titleOfClass":"*W EXP 12/17/202","cusip":"76155X118","value":1875980,"shares":200000,"shareType":"SH","priorValue":358000,"priorShares":200000},{"issuer":"PROFOUND MED CORP","titleOfClass":"COM NEW","cusip":"74319B502","value":1694107,"shares":254753,"shareType":"SH","priorValue":1650799,"priorShares":254753},{"issuer":"RENOVORX INC","titleOfClass":"COM NEW","cusip":"75989R107","value":1632776,"shares":1666098,"shareType":"SH","priorValue":1682759,"priorShares":1666098},{"issuer":"MODULAR MED INC","titleOfClass":"COM NEW","cusip":"60785L306","value":1516437,"shares":336986,"shareType":"SH","priorValue":987286,"priorShares":186986},{"issuer":"VENU HLDG CORP","titleOfClass":"COM","cusip":"92333E104","value":1362000,"shares":600000,"shareType":"SH","priorValue":1986000,"priorShares":600000},{"issuer":"TALPHERA INC","titleOfClass":"COM NEW","cusip":"00444T209","value":1347021,"shares":1307787,"shareType":"SH","priorValue":976786,"priorShares":1307787},{"issuer":"QT IMAGING HLDGS INC","titleOfClass":"COM","cusip":"746962307","value":1288835,"shares":316667,"shareType":"SH","priorValue":978329,"priorShares":166666},{"issuer":"LIBERTY LIVE HOLDINGS INC","titleOfClass":"COM SHS SER C","cusip":"530909308","value":1174827,"shares":13802,"shareType":"SH","priorValue":1174827,"priorShares":13802},{"issuer":"LIBERTY DEFENSE HLDGS LTD","titleOfClass":"COM NEW","cusip":"53044R867","value":1119441,"shares":277777,"shareType":"SH"},{"issuer":"REIN THERAPEUTICS INC","titleOfClass":"COM NEW","cusip":"00887A204","value":1040000,"shares":1000000,"shareType":"SH"},{"issuer":"OWLET INC","titleOfClass":"CL A NEW","cusip":"69120X206","value":987280,"shares":172000,"shareType":"SH","priorValue":884080,"priorShares":172000},{"issuer":"SINTX TECHNOLOGIES INC","titleOfClass":"COM NEW","cusip":"829392703","value":978034,"shares":523013,"shareType":"SH"},{"issuer":"CELLECTAR BIOSCIENCES INC","titleOfClass":"COM NEW","cusip":"15117F880","value":802528,"shares":288679,"shareType":"SH","priorValue":254000,"priorShares":100000},{"issuer":"MAIA BIOTECHNOLOGY INC","titleOfClass":"COM","cusip":"552641102","value":720000,"shares":500000,"shareType":"SH","priorValue":700000,"priorShares":500000},{"issuer":"5E ADVANCED MATERIALS INC","titleOfClass":"COM NEW","cusip":"33830Q208","value":637696,"shares":458774,"shareType":"SH","priorValue":700000,"priorShares":500000},{"issuer":"PIXELWORKS INC","titleOfClass":"COM","cusip":"72581M404","value":525417,"shares":84269,"shareType":"SH","priorValue":1085481,"priorShares":201015},{"issuer":"IMMUCELL CORP","titleOfClass":"COM PAR","cusip":"452525306","value":502500,"shares":50000,"shareType":"SH","priorValue":643090,"priorShares":101594},{"issuer":"LIBERTY LIVE HOLDINGS INC","titleOfClass":"COM SER A","cusip":"530909100","value":501719,"shares":6047,"shareType":"SH","priorValue":501719,"priorShares":6047},{"issuer":"HEARTBEAM INC","titleOfClass":"COM","cusip":"42238H108","value":468750,"shares":625000,"shareType":"SH"},{"issuer":"SPROTT ASSET MANAGEMENT LP","titleOfClass":"PHYSICAL GOLD TR","cusip":"85207H104","value":378332,"shares":12540,"shareType":"SH","priorValue":444418,"priorShares":12540},{"issuer":"NASUS PHARMA LTD","titleOfClass":"ORD SHS","cusip":"M7071P109","value":314468,"shares":89848,"shareType":"SH","priorValue":199463,"priorShares":89848},{"issuer":"BANK OF NY MELLON CORP","titleOfClass":"COM","cusip":"064058100","value":289220,"shares":2000,"shareType":"SH","priorValue":237260,"priorShares":2000},{"issuer":"LIONSGATE STUDIOS CORP","titleOfClass":"COM","cusip":"53626N102","value":251283,"shares":16413,"shareType":"SH","priorValue":157401,"priorShares":16413},{"issuer":"PAYPAL HLDGS INC","titleOfClass":"COM","cusip":"70450Y103","value":228854,"shares":5300,"shareType":"SH","priorValue":239719,"priorShares":5300},{"issuer":"CADENCE DESIGN SYSTEM INC","titleOfClass":"COM","cusip":"127387108","value":197043,"shares":525,"shareType":"SH","priorValue":145882,"priorShares":525},{"issuer":"MULTISENSOR AI HOLDINGS INC","titleOfClass":"COM","cusip":"456948207","value":159228,"shares":30562,"shareType":"SH"},{"issuer":"SIRIUSXM HOLDINGS INC","titleOfClass":"COMMON STOCK","cusip":"829933100","value":149502,"shares":5061,"shareType":"SH","priorValue":116808,"priorShares":5061},{"issuer":"EXXON MOBIL CORP","titleOfClass":"COM","cusip":"30231G102","value":146974,"shares":1075,"shareType":"SH","priorValue":182385,"priorShares":1075},{"issuer":"ERNEXA THERAPEUTICS INC","titleOfClass":"*W EXP 02/04/203","cusip":"114082118","value":142600,"shares":2000000,"shareType":"SH","priorValue":56000,"priorShares":2000000},{"issuer":"TRANSMEDICS GROUP INC","titleOfClass":"COM","cusip":"89377M109","value":139482,"shares":2100,"shareType":"SH","priorValue":208761,"priorShares":2100},{"issuer":"ALLIANCE ENTERTAINMENT HOLDI","titleOfClass":"*W EXP 02/11/202","cusip":"01861F110","value":89000,"shares":200000,"shareType":"SH","priorValue":120020,"priorShares":200000},{"issuer":"ARK ETF TR","titleOfClass":"BLOC FIN INN ETF","cusip":"00214Q708","value":47352,"shares":1200,"shareType":"SH","priorValue":45612,"priorShares":1200},{"issuer":"ARK ETF TR","titleOfClass":"NEXT GNRTN INTER","cusip":"00214Q401","value":43458,"shares":300,"shareType":"SH","priorValue":36183,"priorShares":300},{"issuer":"IONQ INC","titleOfClass":"COM","cusip":"46222L108","value":39945,"shares":750,"shareType":"SH","priorValue":21623,"priorShares":750},{"issuer":"BEYOND AIR INC","titleOfClass":"COM NEW","cusip":"08862L202","value":38565,"shares":86489,"shareType":"SH","priorValue":59695,"priorShares":86489},{"issuer":"D-WAVE QUANTUM INC","titleOfClass":"COM","cusip":"26740W109","value":35985,"shares":1500,"shareType":"SH","priorValue":21645,"priorShares":1500},{"issuer":"ARK ETF TR","titleOfClass":"GENOMIC REV ETF","cusip":"00214Q302","value":34700,"shares":825,"shareType":"SH","priorValue":21797,"priorShares":825},{"issuer":"STARZ ENTERTAINMENT CORP.","titleOfClass":"COM","cusip":"855919106","value":31515,"shares":1092,"shareType":"SH","priorValue":12558,"priorShares":1092},{"issuer":"RIGETTI COMPUTING INC","titleOfClass":"COMMON STOCK","cusip":"76655K103","value":28980,"shares":1500,"shareType":"SH","priorValue":21060,"priorShares":1500},{"issuer":"GENEDX HOLDINGS CORP","titleOfClass":"COM CL A","cusip":"81663L200","value":20870,"shares":304,"shareType":"SH","priorValue":19523,"priorShares":304},{"issuer":"OPPFI INC","titleOfClass":"*W EXP 07/20/202","cusip":"68386H111","value":7500,"shares":250000,"shareType":"SH","priorValue":32500,"priorShares":250000},{"issuer":"X4 PHARMACEUTICALS INC","titleOfClass":"COM NEW","cusip":"98420X202","value":2779,"shares":595,"shareType":"SH","priorValue":2457,"priorShares":595},{"issuer":"SAVERONE 2014 LTD","titleOfClass":"*W EXP 06/02/202","cusip":"80516T113","value":1331,"shares":121000,"shareType":"SH","priorValue":1246,"priorShares":121000}]},"notice":"Compiled from public SEC Form ADV filings on the dates in `sources`. Facts as filed; not a rating, ranking, or recommendation. Niva is not affiliated with this firm. Disciplinary history is deliberately not included here or on the page; the SEC publishes the complete record at the `iapdUrl` above."}